Correlation Between Caribou Biosciences and Karyopharm Therapeutics
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Karyopharm Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Karyopharm Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Karyopharm Therapeutics, you can compare the effects of market volatilities on Caribou Biosciences and Karyopharm Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Karyopharm Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Karyopharm Therapeutics.
Diversification Opportunities for Caribou Biosciences and Karyopharm Therapeutics
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Caribou and Karyopharm is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Karyopharm Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Karyopharm Therapeutics and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Karyopharm Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Karyopharm Therapeutics has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Karyopharm Therapeutics go up and down completely randomly.
Pair Corralation between Caribou Biosciences and Karyopharm Therapeutics
Given the investment horizon of 90 days Caribou Biosciences is expected to generate 1.0 times more return on investment than Karyopharm Therapeutics. However, Caribou Biosciences is 1.0 times more volatile than Karyopharm Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Karyopharm Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 188.00 in Caribou Biosciences on August 29, 2024 and sell it today you would earn a total of 14.00 from holding Caribou Biosciences or generate 7.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Caribou Biosciences vs. Karyopharm Therapeutics
Performance |
| Timeline |
| Caribou Biosciences |
| Karyopharm Therapeutics |
Caribou Biosciences and Karyopharm Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Caribou Biosciences and Karyopharm Therapeutics
The main advantage of trading using opposite Caribou Biosciences and Karyopharm Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Karyopharm Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Karyopharm Therapeutics will offset losses from the drop in Karyopharm Therapeutics' long position.| Caribou Biosciences vs. Eliem Therapeutics | Caribou Biosciences vs. Scpharmaceuticals | Caribou Biosciences vs. Milestone Pharmaceuticals | Caribou Biosciences vs. Seres Therapeutics |
| Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |